In biostimulator treatments, a strategic approach rather than simple injection is becoming the key to differentiation.
Biostimulators are treatments in which components such as PLLA, PCL, and CaHA induce collagen production in the body. Even with the same product, results can vary significantly depending on dilution ratio, injection depth, injection volume, and treatment intervals.
Dr. 김민승 emphasized that biostimulator protocols should be designed by comprehensively considering the patient's skin thickness, degree of aging, lifestyle patterns, and other factors. Product selection is no longer the differentiator — strategy development is now the competitive advantage.
Source: 데일리팜